ABT - ABBOTT LABORATORIES
113.1
-0.510 -0.451%
Share volume: 4,603,868
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$113.61
-0.51
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 07-31-2024 | 10-31-2024 | 02-21-2025 | 04-30-2025 | 07-30-2025 | 10-29-2025 | 02-20-2026 | |
| Total revenue | 9.964 B | 10.377 B | 10.635 B | 10.974 B | 10.358 B | 11.142 B | 11.369 B | 11.459 B | |
| Cost of revenue | 4.463 B | 4.603 B | 4.698 B | 4.942 B | 4.468 B | 4.854 B | 5.075 B | 4.922 B | |
| Gross profit | 5.501 B | 5.774 B | 5.937 B | 6.032 B | 5.890 B | 6.288 B | 6.294 B | 6.537 B | |
| 4.96% | 2.82% | 1.60% | -2.35% | 6.76% | 0.10% | 3.86% | |||
| Operating expenses | 3.643 B | 3.634 B | 3.608 B | 3.656 B | 3.777 B | 3.816 B | 3.817 B | 3.864 B | |
| Selling general and admin | 2.959 B | 2.936 B | 2.895 B | 2.907 B | 3.061 B | 3.091 B | 3.051 B | 3.129 B | |
| Research and development | 684.000 M | 698.000 M | 713.000 M | 749.000 M | 716.000 M | 725.000 M | 766.000 M | 735.000 M | |
| Total expenses | 4.115 B | 4.105 B | 4.078 B | 4.121 B | 4.197 B | 4.236 B | 4.237 B | 4.286 B | |
| -0.24% | -0.66% | 1.05% | 1.84% | 0.93% | 0.02% | 1.16% | |||
| Operating income | 1.386 B | 1.669 B | 1.859 B | 1.911 B | 1.693 B | 2.052 B | 2.057 B | 2.251 B | |
| Ebit | 1.497 B | 1.665 B | 1.991 B | 2.075 B | 1.827 B | 2.200 B | 2.224 B | 2.400 B | |
| Pretax income | 1.436 B | 1.607 B | 1.940 B | 2.030 B | 1.778 B | 2.150 B | 2.180 B | 2.358 B | |
| 11.91% | 20.72% | 4.64% | -12.41% | 20.92% | 1.40% | 8.17% | |||
| Income tax | 211.000 M | 305.000 M | 294.000 M | -7.199 B | 453.000 M | 371.000 M | 536.000 M | 582.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.225 B | 1.302 B | 1.646 B | 9.229 B | 1.325 B | 1.779 B | 1.644 B | 1.776 B | |
| 6.29% | 26.42% | 460.69% | -85.64% | 34.26% | -7.59% | 8.03% |